EcoDrugPlus

Epoxide Hydrolase 2

Ensembl ID : ENSELUG00000017888
Gene Symbol: EPHX2
2 Cross references
204 Possible Orthologues:

Equilibrative Nucleoside Transporter 1

Ensembl ID : ENSELUG00000004077
Gene Symbol: LOC105010266
3 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSELUG00000023565
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSELUG00000016292
Gene Symbol: ERBB3
3 Cross references
210 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSELUG00000012207
Gene Symbol: ERBB4
3 Cross references
225 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSELUG00000000670
Gene Symbol: ESR1
1 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta

Ensembl ID : ENSELUG00000012140
Gene Symbol: LOC105015549
3 Cross references
208 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSELUG00000006276
Gene Symbol: LOC105017652
3 Cross references
200 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSELUG00000001603
Gene Symbol: LOC105015729
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSELUG00000014306
Gene Symbol: XPO1
3 Cross references
219 Possible Orthologues:

Exportin 1

Ensembl ID : ENSELUG00000012707
Gene Symbol: XPO1
3 Cross references
229 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSELUG00000012905
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).